Gonorrhea has been intractable to the development of a vaccine, but the US biotech TherapyX Inc. working with the Netherlands R&D organization Intravacc have induced immune responses in primates with their mucosal immunization approach, NGoXIM, and Therapyx has just received a $2.8m US government grant to support the research.
Neisseria gonorrhoeae infections are usually treated with penicillin or other antibiotics, but with resistant strains becoming more common, and most individuals not developing protective immunity from earlier